|
Select the Calendar Year to View:
|
|
|
|
|
|
|
| March 2026 | 4/3/2026 | $0.00 | $0.00 | |
| February 2026 | 3/2/2026 | $0.00 | $0.00 | |
| January 2026 | 2/4/2026 | $0.00 | $0.00 | |
| |
No non-zero expenditures reported.
|
| Representative Name | Paid | Cat. Pay | Branch | Dates Registered |
|
New Orleans Redevelopment Authority
| Yes | $100,000 - $249,999 |
Legislative
|
1/1/2009
-
3/10/2009
|
|
Novo Nordisk Inc.
| Yes | $25,000 - $49,999 |
Legislative and Executive and Local Government Lobbying
|
4/11/2022
-
current
|
|
Pfizer Inc.
| Yes | $50,000 - $99,999 |
Legislative and Executive
|
1/21/2010
-
12/31/2012
|
|
Pfizer Inc.
| Yes | $50,000 - $99,999 |
Legislative and Executive
|
3/14/2013
-
2/19/2013
|
|
Pfizer Inc.
| Yes | $50,000 - $99,999 |
Legislative and Executive and Local Government Lobbying
|
2/19/2013
-
4/4/2022
|
|
No business relationships reported.
|
La R.S. 24:53.1 requires that before engaging in lobbying activity in Louisiana on behalf of a
foreign adversary as defined in La R.S. 24:51(9), any person who participates in such
lobbying shall file a disclosure with the Louisiana Board of Ethics. (Effective Dec. 1, 2025)
La R.S. 24:53.2 requires that any person who lobbies on behalf of a foreign corporation or
any entity whose headquarters or principal place of business is located in a nation or country identified in
15 CFR Part 791.4,
as revised from time to time, shall file a disclosure with the Louisiana Board of Ethics. (Effective Dec. 1, 2025)
|
MR. DARRICK ANTOINE LEBEOUF has not filed any disclosures of lobbying on behalf of a foreign adversary or corporation.
|